{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:50:30Z","timestamp":1768780230568,"version":"3.49.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011039","name":"Swiss Centre of Applied Human Toxicology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011039","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["31003A-179400"],"award-info":[{"award-number":["31003A-179400"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["320030-170249"],"award-info":[{"award-number":["320030-170249"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jsbmb.2018.10.016","type":"journal-article","created":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T17:50:52Z","timestamp":1540749052000},"page":"212-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study"],"prefix":"10.1016","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7371-8641","authenticated-orcid":false,"given":"Petra","family":"Strajhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Vizeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Patt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick C.","family":"Dolder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise V.","family":"Kratschmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-9659","authenticated-orcid":false,"given":"Matthias E.","family":"Liechti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-2712","authenticated-orcid":false,"given":"Alex","family":"Odermatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsbmb.2018.10.016_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1185\/030079908X242737","article-title":"Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers","volume":"24","author":"Krishnan","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"issue":"12","key":"10.1016\/j.jsbmb.2018.10.016_bib0010","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/0044011-200828120-00002","article-title":"Metabolism, distribution and elimination of lisdexamfetamine dimesylate: open-label, single-centre, phase I study in healthy adult volunteers","volume":"28","author":"Krishnan","year":"2008","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0015","series-title":"Monitoring the Future: National Survey Results on Drug Use, 1975\u20132013: Volume 2, College Students and Adults Ages 19-55","author":"Johnston","year":"2014"},{"issue":"10","key":"10.1016\/j.jsbmb.2018.10.016_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141289","article-title":"The use of prescription drugs, recreational drugs, and \"soft enhancers\" for cognitive enhancement among Swiss secondary school students","volume":"10","author":"Liakoni","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jsbmb.2018.10.016_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144402","article-title":"Swiss university students\u2019 attitudes toward pharmacological cognitive enhancement","volume":"10","author":"Maier","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/NDT.S9749","article-title":"Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine","volume":"6","author":"Pennick","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"4","key":"10.1016\/j.jsbmb.2018.10.016_bib0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0269881109103113","article-title":"Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse","volume":"23","author":"Jasinski","year":"2009","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jsbmb.2018.10.016_bib0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, past and present\u2014a pharmacological and clinical perspective","volume":"27","author":"Heal","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jsbmb.2018.10.016_bib0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40263-014-0166-2","article-title":"A systematic review of the safety of lisdexamfetamine dimesylate","volume":"28","author":"Coghill","year":"2014","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.jsbmb.2018.10.016_bib0050","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.neuropharm.2012.07.008","article-title":"Lisdexamfetamine and immediate release d-amfetamine - differences in pharmacokinetic\/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activity","volume":"63","author":"Rowley","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0055","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fphar.2017.00617","article-title":"Pharmacokinetics and pharmacodynamics of lisdexamfetamine compared with D-amphetamine in healthy subjects","volume":"8","author":"Dolder","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.jsbmb.2018.10.016_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145635","article-title":"Stress-induced in vivo recruitment of human cytotoxic natural killer cells favors subsets with distinct receptor profiles and associates with increased epinephrine levels","volume":"10","author":"Bigler","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000364879","article-title":"Acute effects of 3,4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects","volume":"100","author":"Seibert","year":"2014","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0070","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/0269881114542454","article-title":"Differential effects of MDMA and methylphenidate on social cognition","volume":"28","author":"Schmid","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S1461145713001132","article-title":"Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone and in combination","volume":"17","author":"Hysek","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5682","key":"10.1016\/j.jsbmb.2018.10.016_bib0080","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/bmj.4.5682.528","article-title":"Influence of amphetamines on plasma corticosteroid and growth hormone levels in man","volume":"4","author":"Besser","year":"1969","journal-title":"Br. Med. J."},{"issue":"1","key":"10.1016\/j.jsbmb.2018.10.016_bib0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1542\/peds.2011-2879","article-title":"Trends of outpatient prescription drug utilization in US children, 2002\u20132010","volume":"130","author":"Chai","year":"2012","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.jsbmb.2018.10.016_bib0090","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/15563650.2015.1027903","article-title":"Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers","volume":"53","author":"Kaland","year":"2015","journal-title":"Clin. Toxicol. (Phila.)"},{"issue":"5","key":"10.1016\/j.jsbmb.2018.10.016_bib0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bbadis.2011.02.003","article-title":"Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications","volume":"1812","author":"Chung","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0100","series-title":"Global Assessment of the State-of-the-Science of Endocrine Disruptors, International Programme on Chemical Safety, WHO Publication No. WHO\/PCS\/EDC\/02.2","author":"Damstra","year":"2002"},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fpsyt.2015.00032","article-title":"Is dysregulation of the HPA-axis a core pathophysiology mediating co-morbid depression in neurodegenerative diseases?","volume":"6","author":"Du","year":"2015","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.jsbmb.2018.10.016_bib0110","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nrc1072","article-title":"The circadian clock: pacemaker and tumour suppressor","volume":"3","author":"Fu","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.jsbmb.2018.10.016_bib0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2011.08.010","article-title":"Circadian clock signals in the adrenal cortex","volume":"349","author":"Ota","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.jsbmb.2018.10.016_bib0120","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1073\/pnas.88.6.2088","article-title":"Corticosterone levels determine individual vulnerability to amphetamine self-administration","volume":"88","author":"Piazza","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jsbmb.2018.10.016_bib0125","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0091-3057(02)00818-3","article-title":"Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase","volume":"73","author":"White","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.jsbmb.2018.10.016_bib0130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/JCP.0b013e31823607f6","article-title":"Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine","volume":"31","author":"Dos Santos","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jsbmb.2018.10.016_bib0135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3109\/00952990903383961","article-title":"Atomoxetine attenuates dextroamphetamine effects in humans","volume":"35","author":"Sofuoglu","year":"2009","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"5","key":"10.1016\/j.jsbmb.2018.10.016_bib0140","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/sj.npp.1300939","article-title":"Personality and the subjective effects of acute amphetamine in healthy volunteers","volume":"31","author":"White","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jsbmb.2018.10.016_bib0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00426906","article-title":"Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate","volume":"58","author":"Brown","year":"1978","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.jsbmb.2018.10.016_bib0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1677\/joe.0.0400391","article-title":"Changes in plasma cortisol induced by dexamphetamine and chlordiazepoxide given alone and in combination in man","volume":"40","author":"Butler","year":"1968","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.jsbmb.2018.10.016_bib0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00004850-198904000-00005","article-title":"The neuroendocrine response to oral dextroamphetamine in normal subjects","volume":"4","author":"Jacobs","year":"1989","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jsbmb.2018.10.016_bib0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0376-8716(03)00172-8","article-title":"Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP","volume":"72","author":"Tancer","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.jsbmb.2018.10.016_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-1781(96)02884-3","article-title":"Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers","volume":"64","author":"Grady","year":"1996","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0170","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/npp.2013.6","article-title":"Neurocircuitry underlying the preferential sensitivity of prefrontal catecholamines to low-dose psychostimulants","volume":"38","author":"Schmeichel","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jsbmb.2018.10.016_bib0175","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.jsbmb.2018.10.016_bib0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bcp.2014.01.024","article-title":"Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives","volume":"88","author":"Simmler","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.jsbmb.2018.10.016_bib0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","article-title":"Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man","volume":"12","author":"Martin","year":"1971","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jsbmb.2018.10.016_bib0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0149-7634(94)00062-6","article-title":"Limbic pathways and hypothalamic neurotransmitters mediating adrenocortical responses to neural stimuli","volume":"19","author":"Feldman","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036476","article-title":"Duloxetine inhibits effects of MDMA (\"ecstasy\") in vitro and in humans in a randomized placebo-controlled laboratory study","volume":"7","author":"Hysek","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jsbmb.2018.10.016_bib0200","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/clpt.2011.78","article-title":"The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (\"ecstasy\") in humans","volume":"90","author":"Hysek","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.jsbmb.2018.10.016_bib0205","doi-asserted-by":"crossref","first-page":"12374","DOI":"10.1111\/jne.12374","article-title":"Acute effects of lysergic acid diethylamide on circulating steroid levels in healthy subjects","volume":"28","author":"Strajhar","year":"2016","journal-title":"J. Neuroendocrinol."},{"issue":"8","key":"10.1016\/j.jsbmb.2018.10.016_bib0210","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.jsbmb.2018.10.016_bib0215","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0893-133X(95)00117-V","article-title":"Neuroendocrine effects of a 20-mg citalopram infusion in healthy males: a placebo-controlled evaluation of citalopram as 5-HT function probe","volume":"14","author":"Seifritz","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.jsbmb.2018.10.016_bib0220","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2007.04.015","article-title":"Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study","volume":"62","author":"Biederman","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jsbmb.2018.10.016_bib0225","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0269881108093841","article-title":"Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers","volume":"23","author":"Jasinski","year":"2009","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jsbmb.2018.10.016_bib0230","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/11588190-000000000-00000","article-title":"Intranasal versus oral administration of lisdexamfetamine dimesylate: a randomized, open-label, two-period, crossover, single-dose, single-centre pharmacokinetic study in healthy adult men","volume":"31","author":"Ermer","year":"2011","journal-title":"Clin. Drug Investig."},{"issue":"1","key":"10.1016\/j.jsbmb.2018.10.016_bib0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pnpbp.2007.05.003","article-title":"Riluzole and D-amphetamine interactions in humans","volume":"32","author":"Sofuoglu","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0240","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000262533","article-title":"Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function","volume":"17","author":"Locatelli","year":"2010","journal-title":"Endocr. Dev."},{"issue":"1","key":"10.1016\/j.jsbmb.2018.10.016_bib0245","first-page":"196P","article-title":"Release by amphetamine in man of growth hormone and corticosteroids: the effects of thymoxamine and propranolol","volume":"39","author":"Besser","year":"1970","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.jsbmb.2018.10.016_bib0250","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF00427446","article-title":"Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man","volume":"84","author":"Nurnberger","year":"1984","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0255","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00213-012-2645-9","article-title":"MDMA enhances \"mind reading\" of positive emotions and impairs \"mind reading\" of negative emotions","volume":"222","author":"Hysek","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.jsbmb.2018.10.016_bib0260","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/jpet.114.222356","article-title":"Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects","volume":"353","author":"Schmid","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.jsbmb.2018.10.016_bib0265","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00004714-199602000-00012","article-title":"Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy men","volume":"16","author":"Brauer","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.jsbmb.2018.10.016_bib0270","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/FPC.0000000000000231","article-title":"Liechti, CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals","volume":"26","author":"Schmid","year":"2016","journal-title":"Pharmacogenet. Genom."},{"issue":"9","key":"10.1016\/j.jsbmb.2018.10.016_bib0275","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1177\/0091270009357346","article-title":"Lisdexamfetamine dimesylate: linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacokinetic study in healthy adult volunteers","volume":"50","author":"Ermer","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0280","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/scan\/nst161","article-title":"MDMA enhances emotional empathy and prosocial behavior","volume":"9","author":"Hysek","year":"2014","journal-title":"Soc. Cogn. Affect. Neurosci."},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0285","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1210\/jc.2011-1143","article-title":"Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects","volume":"96","author":"Simmler","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2018.10.016_bib0290","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0269881112454231","article-title":"MDMA can increase cortisol levels by 800% in dance clubbers","volume":"27","author":"Parrott","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"3\u20134","key":"10.1016\/j.jsbmb.2018.10.016_bib0295","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000253551","article-title":"Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users","volume":"60","author":"Parrott","year":"2009","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.jsbmb.2018.10.016_bib0300","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0022-3565(24)29682-8","article-title":"Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans","volume":"296","author":"Pacifici","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.jsbmb.2018.10.016_bib0305","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00213-002-1131-1","article-title":"Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans","volume":"162","author":"Harris","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"issue":"9","key":"10.1016\/j.jsbmb.2018.10.016_bib0310","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/sj.npp.1300223","article-title":"Altering cortisol level does not change the pleasurable effects of methamphetamine in humans","volume":"28","author":"Harris","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2018.10.016_bib0315","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0306-4530(01)00036-1","article-title":"Temporal concordance of cocaine effects on mood states and neuroendocrine hormones","volume":"27","author":"Mendelson","year":"2002","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"10.1016\/j.jsbmb.2018.10.016_bib0320","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/npp.2011.130","article-title":"Effects of progesterone and testosterone on cocaine self-administration and cocaine discrimination by female rhesus monkeys","volume":"36","author":"Mello","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.jsbmb.2018.10.016_bib0325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tem.2009.12.011","article-title":"Interactions of the circadian CLOCK system and the HPA axis","volume":"21","author":"Nader","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"issue":"5-6","key":"10.1016\/j.jsbmb.2018.10.016_bib0330","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/FBP.0000000000000060","article-title":"MDMA, cortisol, and heightened stress in recreational ecstasy users","volume":"25","author":"Parrott","year":"2014","journal-title":"Behav. Pharmacol."},{"issue":"8","key":"10.1016\/j.jsbmb.2018.10.016_bib0335","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1017\/S1461145714000066","article-title":"In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users","volume":"17","author":"Frokjaer","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.jsbmb.2018.10.016_bib0340","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11481-010-9206-y","article-title":"Psychiatric symptoms and HPA axis function in adolescent methamphetamine users","volume":"5","author":"King","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.jsbmb.2018.10.016_bib0345","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/jnp.3.1.41","article-title":"Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder","volume":"3","author":"Lurie","year":"1991","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jsbmb.2018.10.016_bib0350","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jpsychires.2011.11.014","article-title":"The change of the cortisol levels in children with ADHD treated by methylphenidate or atomoxetine","volume":"46","author":"Chen","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.jsbmb.2018.10.016_bib0355","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/1087054712466139","article-title":"The trend in morning levels of salivary cortisol in children with ADHD during 6 months of methylphenidate treatment","volume":"21","author":"Wang","year":"2017","journal-title":"J. Atten. Disord."},{"issue":"3","key":"10.1016\/j.jsbmb.2018.10.016_bib0360","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000073626","article-title":"Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder","volume":"48","author":"Maayan","year":"2003","journal-title":"Neuropsychobiology"},{"issue":"8","key":"10.1016\/j.jsbmb.2018.10.016_bib0365","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/11634340-000000000-00000","article-title":"Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder","volume":"26","author":"Steer","year":"2012","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.jsbmb.2018.10.016_bib0370","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaac.2011.01.007","article-title":"Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit\/hyperactivity disorder","volume":"50","author":"Findling","year":"2011","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jsbmb.2018.10.016_bib0375","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1744-9081-5-34","article-title":"Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit\/hyperactivity disorder","volume":"5","author":"Adler","year":"2009","journal-title":"Behav. Brain Funct."},{"issue":"5","key":"10.1016\/j.jsbmb.2018.10.016_bib0380","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40261-015-0354-y","article-title":"Lisdexamfetamine dimesylate: prodrug delivery, amphetamine exposure and duration of efficacy","volume":"36","author":"Ermer","year":"2016","journal-title":"Clin. Drug Investig."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076018306459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076018306459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:01:10Z","timestamp":1760745670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076018306459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":76,"alternative-id":["S0960076018306459"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2018.10.016","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2018.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}